Literature DB >> 9586718

Use of radiochromic dosimetry film for HDR brachytherapy quality assurance.

K D Steidley1.   

Abstract

An important quality assurance (QA) procedure in high dose rate (HDR) remote afterloading brachytherapy is the verification of the system's control of the source by a direct test with dosimetry medium prior to the patient's first treatment. In this test radiochromic film is placed in direct contact with the applicator and the patient's proposed treatment is then run with their EPROM card. Examination of the film allows a quick appraisal of step size, number of steps, and offset. Advantages of this film include self-development so the image may be viewed immediately, insensitivity to normal room light, and archivability. The cost is about U.S. $2 per clinical case.

Entities:  

Mesh:

Year:  1998        PMID: 9586718     DOI: 10.1016/s0958-3947(97)00114-3

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  3 in total

1.  Development of an HDR-BT QA tool for source position verification.

Authors:  Yu Kumazaki; Ryuta Hirai; Mitsunobu Igari; Nao Kobayashi; Shohei Okazaki; Takanori Abe; Tomoaki Tamaki; Shin-Ei Noda; Shingo Kato
Journal:  J Appl Clin Med Phys       Date:  2020-11-02       Impact factor: 2.102

2.  Evaluating dosimetric accuracy of the 6 MV calibration on EBT3 film in the use of Ir-192 high dose rate brachytherapy.

Authors:  Lyu Huang; Hani Gaballa; Jenghwa Chang
Journal:  J Appl Clin Med Phys       Date:  2022-02-28       Impact factor: 2.243

3.  A review of nonstandardized applicators digitization in Nucletron™ HDR procedures.

Authors:  Kelin Wang; Michele S Ferenci; Alberto de la Zerda; Kyle R Padgett; Elizabeth L Bossart; Ming Chao; Hua Shao; Mutain Zhang
Journal:  J Appl Clin Med Phys       Date:  2017-08-30       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.